Discover how scientists are mapping infection-enhancing epitopes of the dengue pr protein to overcome antibody-dependent enhancement and create safer vaccines.
Discover how the gp40/15 protein complex in Cryptosporidium could lead to breakthrough treatments and vaccines against this deadly parasite.
Exploring strategies to improve hepatitis B vaccine effectiveness in HIV-positive individuals through optimized dosing, novel adjuvants, and timing considerations.
Exploring the fascinating world of S. aureus antigens and how they hold the key to unlocking new protective strategies against this formidable pathogen.
Discover how pneumococcal conjugate vaccines reduce serious infection risk by nearly half in inflammatory arthritis patients, with long-term protection data.
Exploring Schistosoma mansoni cercarial elastase and its potential for vaccine development against schistosomiasis
Explore how Theiler's Murine Encephalomyelitis Virus (TMEV) is being engineered as a novel vaccine platform for cancer immunotherapy and other therapeutic applications.
Research on BNT162b2 mRNA COVID-19 vaccine effectiveness in pediatric cancer patients reveals crucial insights for protecting immunocompromised children.
Discover how BCG vaccine activates two distinct suppressor cell populations in mice and the implications for immunology and medicine.
Discover how targeting the dengue virus's NS1 protein directly to dendritic cells creates powerful protective immunity against this deadly disease.